| Otic Disorders | 29 | May 20, 2013 |
| Stye and Blepharitis | 9 | May 20, 2013 |
| Keratoconjunctivitis | 16 | May 20, 2013 |
| Conjunctivitis | 20 | May 20, 2013 |
| Age-Related Macular Degeneration | 26 | May 17, 2013 |
| Glaucoma II | 14 | May 17, 2013 |
| Glaucoma I | 38 | May 17, 2013 |
| Ears, Eyes, and Nose III | 25 | May 16, 2013 |
| Ears, Eyes, and Nose II | 24 | May 16, 2013 |
| Ears, Eyes, and Nose I | 34 | May 15, 2013 |
| Photosensitivity and Hair Disorders | 15 | May 13, 2013 |
| Drug-Induced Skin Reactions | 21 | May 13, 2013 |
| Psoriasis II | 25 | May 13, 2013 |
| Psoriasis I | 30 | May 13, 2013 |
| Cutaneous Infections | 26 | May 12, 2013 |
| Eczema and Dermatitis | 26 | May 12, 2013 |
| Rosacea | 13 | May 12, 2013 |
| Acne Vulgaris | 31 | May 12, 2013 |
| Dermatological Pharmacology | 37 | May 10, 2013 |
| Skin Anatomy, Physiology, and Drug Delivery | 15 | May 10, 2013 |
| Monoclonal Antibodies | 6 | May 10, 2013 |
| Allergic Rhinitis | 38 | May 9, 2013 |
| Allergic Reactions and Steroid Pharmacology | 24 | May 9, 2013 |
| Histamine | 21 | May 8, 2013 |
| VTE Pharmacotherapy II | 23 | May 1, 2013 |
| VTE Pharmacotherapy I | 20 | April 30, 2013 |
| Hemorrhagic Stroke | 10 | April 30, 2013 |
| Ischemic Stroke | 36 | April 30, 2013 |
| Stroke | 20 | April 30, 2013 |
| Supraventricular and Ventricular Arrhythmias II | 21 | April 28, 2013 |
| Supraventricular and Ventricular Arrhythmias I | 26 | April 28, 2013 |
| Top 300 Drugs VI (generic to dosage forms) | 51 | April 24, 2013 |
| Top 300 Drugs VI (generic to class) | 51 | April 24, 2013 |
| Top 300 Drugs VI (brand to generic) | 51 | April 24, 2013 |
| Stroke Pathophysiology and Pharmacology | 21 | April 23, 2013 |
| Cardiovascular Physical Assessment | 34 | April 23, 2013 |
| Acute Decompensated Heart Failure Pharmacotherapy | 25 | April 17, 2013 |
| Chronic Heart Failure Pharmacotherapy II | 35 | April 17, 2013 |
| Chronic Heart Failure Pharmacotherapy I | 25 | April 17, 2013 |
| Heart Failure | 18 | April 17, 2013 |
| Atrial Fibrillation Pharmacotherapy IV | 18 | April 16, 2013 |
| Atrial Fibrillation Pharmacotherapy III | 21 | April 16, 2013 |
| Atrial Fibrillation Pharmacotherapy II | 19 | April 16, 2013 |
| Atrial Fibrillation Pharmacotherapy I | 19 | April 16, 2013 |
| Top 300 Drugs V (generic to dosage forms) | 50 | April 15, 2013 |
| Top 300 Drugs V (generic to class) | 50 | April 15, 2013 |
| Top 300 Drugs V (brand to generic) | 50 | April 15, 2013 |
| Shock | 44 | March 31, 2013 |
| Secondary Prevention | 18 | March 29, 2013 |
| STE ACS | 28 | March 29, 2013 |
| NSTE ACS | 36 | March 29, 2013 |
| Acute Coronary Syndrome Background | 13 | March 29, 2013 |
| Parenteral Anticoagulants II | 35 | March 29, 2013 |
| Parenteral Anticoagulants I | 36 | March 27, 2013 |
| Oral Anticoagulants II | 36 | March 27, 2013 |
| Oral Anticoagulants I | 39 | March 27, 2013 |
| Warfarin | 12 | March 22, 2013 |
| Acute Coronary Syndrome III | 22 | March 21, 2013 |
| Acute Coronary Syndrome II | 14 | March 20, 2013 |
| Acute Coronary Syndrome I | 11 | March 20, 2013 |
| Ischemic Heart Disease Pharmacotherapy III | 16 | March 20, 2013 |
| Ischemic Heart Disease Pharmacotherapy II | 32 | March 18, 2013 |
| Ischemic Heart Disease Pharmacotherapy I | 34 | March 18, 2013 |
| Ischemic Heart Disease | 40 | March 18, 2013 |
| EKG Interpretation | 31 | March 18, 2013 |
| Top 300 Drugs IV (generic to class) | 50 | March 15, 2013 |
| Top 300 Drugs IV (generic to dosage forms) | 50 | March 15, 2013 |
| Top 300 Drugs IV (brand to generic) | 50 | March 15, 2013 |
| Peripheral Artery Disease | 20 | March 13, 2013 |
| Hyperlipidemia II | 41 | March 13, 2013 |
| Hyperlipidemia I | 34 | March 13, 2013 |
| Peripheral Artery Disease | 10 | March 11, 2013 |
| Dyslipidemia | 33 | March 11, 2013 |
| Hypertension II | 34 | March 11, 2013 |
| Hypertension I | 40 | March 11, 2013 |
| Calcium Entry Blockers and Vasodilators | 26 | March 9, 2013 |
| The RAS System | 24 | March 8, 2013 |
| Homeostasis and Water Conservation | 15 | March 8, 2013 |
| Sympathoplegic Agents | 25 | March 6, 2013 |
| Cardio Physiology Review | 29 | March 6, 2013 |
| Urinary Incontinence | 45 | February 27, 2013 |
| Benign Prostatic Hyperplasia | 28 | February 25, 2013 |
| Erectile Dysfunction | 34 | February 25, 2013 |
| Special Populations | 16 | February 25, 2013 |
| Acid-Base Disorders II | 30 | February 25, 2013 |
| Acid-Base Disorders I | 32 | February 25, 2013 |
| Top 300 Drugs III (generic to dosage forms) | 45 | February 22, 2013 |
| Top 300 Drugs III (brand to class) | 41 | February 22, 2013 |
| Top 300 Drugs III (brand-generic) | 44 | February 21, 2013 |
| Drugs and Dosing | 34 | February 17, 2013 |
| Drug-Induced Kidney Disease | 29 | February 16, 2013 |
| Acute Kidney Injury | 36 | February 16, 2013 |
| Renal Replacement Therapies | 24 | February 13, 2013 |
| Anemia | 44 | February 12, 2013 |
| Complications of Chronic Kidney Disease | 38 | February 4, 2013 |
| Chronic Kidney Disease | 26 | February 4, 2013 |
| Fluids | 30 | February 4, 2013 |
| Sodium and Water | 44 | February 3, 2013 |
| Magnesium | 9 | February 3, 2013 |
| Potassium | 24 | February 3, 2013 |
| Phosphorus | 19 | February 3, 2013 |
| Calcium | 31 | February 3, 2013 |
| Top 300 Drugs II (generic-dosage forms) | 50 | January 29, 2013 |
| Top 300 Drugs II (generic-class) | 50 | January 29, 2013 |
| Top 300 Drugs II (brand-generic) | 50 | January 29, 2013 |
| Renin-Angiotensin System Drugs | 16 | January 28, 2013 |
| Pharmacology of Diuretics | 35 | January 28, 2013 |
| Renal Monitoring | 22 | January 27, 2013 |
| Renal Anatomy and Physiology II | 29 | January 27, 2013 |
| Renal Anatomy and Physiology I | 42 | January 24, 2013 |
| Interpretation of Lab Diagnostic Tests | 25 | January 16, 2013 |
| Top 300 Drugs I (generic-dosage form) | 50 | January 10, 2013 |
| Top 300 Drugs I (generic-class) | 50 | January 10, 2013 |
| Top 300 Drugs I (brand-generic) | 50 | January 2, 2013 |
| Drug Discovery (Lead Optimization) II | 9 | December 10, 2012 |
| Drug Discovery (Lead Optimization) I | 19 | December 10, 2012 |
| Toxicity Fundamentals | 25 | November 27, 2012 |
| Equations | 9 | November 19, 2012 |
| CYPs | 10 | November 18, 2012 |
| Solution Stability of Drugs | 19 | November 13, 2012 |
| Drug Metabolism | 26 | November 6, 2012 |
| Blood Brain Barrier | 15 | November 1, 2012 |
| Transporters | 6 | November 1, 2012 |
| Permeability | 5 | November 1, 2012 |
| pKa and Solubility of Compounds | 4 | October 24, 2012 |
| Bioavailability and Bioequivalence | 26 | October 23, 2012 |
| Volume of Distribution | 12 | October 23, 2012 |
| Drug Distribution | 17 | October 23, 2012 |
| Lipophilicity | 5 | October 23, 2012 |
| Physiochemical Properties | 14 | October 23, 2012 |
| Intravenous Administration | 15 | October 23, 2012 |
| Measurement of Drug Concentration | 12 | October 23, 2012 |
| Pharmacokinetic Modeling | 13 | October 23, 2012 |
| Drug-Like Properties II | 25 | October 22, 2012 |
| Drug-Like Properties I | 14 | October 22, 2012 |
| PDBI Intro | 13 | October 18, 2012 |
| Parasite Trigger Words | 17 | October 3, 2012 |
| Diarrhea Parasites | 6 | October 3, 2012 |
| Trypanosomes | 5 | October 3, 2012 |
| Leishmania | 5 | October 3, 2012 |
| Toxoplasma | 5 | October 3, 2012 |
| Trichomonas | 5 | October 3, 2012 |
| Malaria | 8 | October 3, 2012 |
| Virus Trigger Words | 30 | October 3, 2012 |
| Fungi Trigger Words | 15 | October 3, 2012 |
| Bioterrorism | 11 | October 1, 2012 |
| Opportunistic Mycoses | 24 | October 1, 2012 |
| Endemic Mycosis | 24 | October 1, 2012 |
| Antifungal Therapy | 27 | October 1, 2012 |
| Supplements | 22 | September 30, 2012 |
| Vitamins | 28 | September 29, 2012 |
| The Musculoskeletal System, Skin, Eye, EENT | 11 | September 29, 2012 |
| Superficial and Deep Fungal Infections | 19 | September 28, 2012 |
| Intro to Mycology | 20 | September 28, 2012 |
| Host Antiviral Responses | 13 | September 27, 2012 |
| Effector Mechanisms of Cell-Mediated Immunity | 8 | September 27, 2012 |
| T Helper Cell Responses | 16 | September 27, 2012 |
| Hepatitis E | 4 | September 26, 2012 |
| Hepatitis D | 4 | September 26, 2012 |
| Hepatitis C | 11 | September 26, 2012 |
| Hepatitis B | 8 | September 26, 2012 |
| Hepatitis A | 5 | September 26, 2012 |
| Poxvirus | 7 | September 25, 2012 |
| HIV | 9 | September 25, 2012 |
| Tolerance and Autoimmunity | 16 | September 23, 2012 |
| Filovirus | 6 | September 21, 2012 |
| Rhabdovirus | 10 | September 21, 2012 |
| Retrovirus | 16 | September 20, 2012 |
| Flavivirus | 8 | September 19, 2012 |
| Togavirus | 12 | September 19, 2012 |
| Orthomyxovirus | 18 | September 19, 2012 |
| Arenavirus | 4 | September 19, 2012 |
| Bunyavirus | 11 | September 19, 2012 |
| Cytomegalovirus | 8 | September 19, 2012 |
| Epstein Barr Virus | 7 | September 19, 2012 |
| Varicella Zoster Virus | 7 | September 19, 2012 |
| Herpes Simplex Virus | 12 | September 19, 2012 |
| Herpes Viruses | 5 | September 19, 2012 |
| Antiviral Drugs | 22 | September 19, 2012 |
| Measles and Mumps | 10 | September 19, 2012 |
| Parainfluenza and Respiratory Syncytial Virus | 14 | September 19, 2012 |
| Reovirus | 9 | September 19, 2012 |
| Coronavirus | 7 | September 19, 2012 |
| Norovirus | 4 | September 19, 2012 |
| Picornavirus | 14 | September 18, 2012 |
| Adenovirus | 9 | September 18, 2012 |
| Parvovirus | 9 | September 18, 2012 |
| Polyomavirus | 11 | September 18, 2012 |
| Papillomavirus | 15 | September 18, 2012 |
| Viral Pathogenesis and Epidemiology | 15 | September 18, 2012 |
| T-Cells | 11 | September 18, 2012 |
| The Urinary Tract and Reproductive System | 8 | September 14, 2012 |
| Infectious Diseases | 12 | September 14, 2012 |
| The Respiratory System | 9 | September 13, 2012 |
| The Cardiovascular System | 8 | September 13, 2012 |
| The Central Nervous System | 12 | September 13, 2012 |
| The Gastrointestinal and Biliary System | 15 | September 13, 2012 |
| Viral Genetics | 11 | September 12, 2012 |
| Viral Replication I and II | 15 | September 12, 2012 |
| Intro to Virology and Virus Structure | 8 | September 12, 2012 |
| Rickettsia and Chlamydia | 27 | September 6, 2012 |
| Mycoplasma and Ureaplasma | 21 | September 5, 2012 |
| Treponema, Borrelia, and Leptospira | 19 | September 5, 2012 |
| Clostridium | 14 | September 5, 2012 |
| Mycobacteria | 17 | September 5, 2012 |
| Cytokine Storms | 12 | September 5, 2012 |
| Humoral Immune Responses | 9 | September 5, 2012 |
| Cases | 20 | September 5, 2012 |
| Bacteria Trigger Words | 29 | September 5, 2012 |
| Effector Mechanisms of Humoral Immunity | 13 | September 5, 2012 |
| Vibrio, Campylobacter and Helicobacter | 17 | September 4, 2012 |
| Traditional Systems of Herbal Medicine | 27 | September 3, 2012 |
| Rules and Regulation | 17 | September 3, 2012 |
| Cancer Chemoprevention by Dietary Agents | 23 | September 3, 2012 |
| Herbal Therapeutics | 31 | September 3, 2012 |
| Introduction | 11 | September 3, 2012 |
| Immunological Methods | 20 | August 29, 2012 |
| Enterobacteriaceae | 28 | August 29, 2012 |
| Pseudomonas | 14 | August 29, 2012 |
| Intro and Mechanisms of Antibacterial Drugs | 29 | August 29, 2012 |
| Neisseria | 22 | August 28, 2012 |
| Anaerobic Bacteria | 17 | August 28, 2012 |
| Complement | 23 | August 28, 2012 |
| Antibody Structure | 27 | August 28, 2012 |
| Innate Immunity I and II | 22 | August 24, 2012 |
| Pasteurellaceae | 26 | August 24, 2012 |
| Corynebacterium, Pertussis, Other Gram-Positive Bacilli | 18 | August 24, 2012 |
| Bacillus | 11 | August 23, 2012 |
| Streptococcus | 42 | August 23, 2012 |
| Staphylococcus | 27 | August 23, 2012 |
| Bacterial Genetics I and II | 23 | August 22, 2012 |
| Bacterial Growth and Metabolism | 27 | August 22, 2012 |
| Bacterial Structures I and II | 26 | August 21, 2012 |
| Intro to Immunology | 38 | August 21, 2012 |
| Bacterial Pathogenesis | 21 | August 20, 2012 |
| Psychotic Disorders | 20 | June 4, 2012 |
| Mood Disorders | 35 | June 3, 2012 |
| Defense Mechanisms | 12 | June 1, 2012 |
| Anxiety and the CNS | 14 | May 30, 2012 |
| Drugs and Dependency | 27 | May 30, 2012 |
| Rhythms and Sleep | 25 | May 30, 2012 |
| EEG and Seizures | 28 | May 30, 2012 |
| Learning and Memory | 18 | May 30, 2012 |
| Cerebral Cortex: Functional Localization | 24 | May 29, 2012 |
| Vestibular and Auditory II | 27 | May 21, 2012 |
| Vestibular and Auditory I | 31 | May 18, 2012 |
| Vision III | 21 | May 18, 2012 |
| Vision II | 25 | May 17, 2012 |
| Vision I | 27 | May 14, 2012 |
| Cerebellum | 22 | May 10, 2012 |
| Basal Ganglia | 16 | May 10, 2012 |
| Motor System | 46 | May 10, 2012 |
| Neurology and Psych Drugs II | 20 | May 9, 2012 |
| Neurology and Psych Drugs I | 25 | May 9, 2012 |
| Pain and Pain Mechanism | 21 | May 9, 2012 |
| Somatosensory Pathways II | 14 | May 9, 2012 |
| Somatosensory Pathways I | 31 | May 9, 2012 |
| Somatosensory System | 24 | May 8, 2012 |
| Thalamic Nuclei | 15 | May 8, 2012 |
| Sensory Processing | 24 | May 7, 2012 |
| Synaptic Integration | 18 | April 30, 2012 |
| Synaptic Transmission II | 21 | April 29, 2012 |
| Synaptic Transmission I | 20 | April 29, 2012 |
| Telencephalon | 24 | April 26, 2012 |
| Diencephalon | 27 | April 26, 2012 |
| Cranial Nerves | 47 | April 26, 2012 |
| Autonomic Nervous System | 25 | April 20, 2012 |
| Spinal Cord | 45 | April 19, 2012 |
| Blood Supply of CNS | 29 | April 19, 2012 |
| Cerebral Spinal Fluid and Meninges | 21 | April 19, 2012 |
| Development of the Nervous System | 40 | April 18, 2012 |
| Orientation to the Nervous System | 29 | April 18, 2012 |
| Neurons and Glia | 19 | April 17, 2012 |
| Pregnancy and Lactation | 23 | April 1, 2012 |
| Female Reproductive System | 30 | April 1, 2012 |
| Male Reproductive System | 20 | April 1, 2012 |
| Mineral Metabolism | 22 | April 1, 2012 |
| Energy Metabolism | 22 | April 1, 2012 |
| Adrenal Steroid Function | 17 | April 1, 2012 |
| The Adrenal Gland | 23 | April 1, 2012 |
| The Thyroid Gland | 23 | April 1, 2012 |
| Neuroendocrinology | 14 | March 27, 2012 |
| The Pituitary Gland | 23 | March 27, 2012 |
| Basic Endocrine Concepts | 31 | March 27, 2012 |
| GI Disorders | 24 | March 26, 2012 |
| Movement of Food Through the GI System | 36 | March 25, 2012 |
| GI Digestion and Absorption | 22 | March 25, 2012 |
| GI Secretion II | 22 | March 25, 2012 |
| GI Secretion I | 35 | March 25, 2012 |
| Intro to GI Physiology II | 14 | March 25, 2012 |
| Intro to GI Physiology I | 41 | March 23, 2012 |
| Cardiac Equations | 14 | March 2, 2012 |
| Local and Humoral Control of Blood Flow | 19 | March 1, 2012 |
| Coronary Heart Disease | 14 | February 29, 2012 |
| Cerebral Blood Flow, Cerebrospinal Fluid, and Brain Metabolism | 38 | February 29, 2012 |
| Neural Control of the Circulation | 32 | February 29, 2012 |
| Top 50 Parenterals II | 25 | February 27, 2012 |
| Cardiovascular Drugs II | 23 | February 27, 2012 |
| Cardiovascular Drugs I | 16 | February 27, 2012 |
| Top 50 Parenterals I | 25 | February 27, 2012 |
| Smooth Muscle | 15 | February 22, 2012 |
| Skeletal Muscle | 18 | February 21, 2012 |
| Membrane Transport, Membrane Potentials, and Action Potentials | 18 | February 21, 2012 |
| Autonomic Nervous System | 34 | February 21, 2012 |
| Receptor Pharmacology | 30 | February 20, 2012 |
| The Cell and Its Functions | 32 | February 20, 2012 |
| Functional Organization of the Body | 26 | February 20, 2012 |
| Metabolism In Cancer Cells | 10 | February 15, 2012 |
| Molecular Biology Of Cancer | 25 | February 14, 2012 |
| Module III Diseases And Drugs | 56 | February 12, 2012 |
| Fibrosis And Inflammation | 19 | February 12, 2012 |
| Extracellular Matrix And Connective Tissue I And II | 27 | February 12, 2012 |
| Eicosanoids | 28 | February 9, 2012 |
| Liver Metabolism II | 24 | February 9, 2012 |
| Liver Metabolism I | 20 | February 9, 2012 |
| Heme Breakdown | 11 | February 8, 2012 |
| Heme Synthesis And Porphyria | 12 | February 8, 2012 |
| O2 Toxicity and Free Radical Injury | 42 | February 8, 2012 |
| Pulmonary Drugs | 9 | February 8, 2012 |
| Blood Plasma Proteins And Coagulation | 34 | February 7, 2012 |
| Biochemistry Of Erythrocytes And Other Blood Cells | 25 | February 7, 2012 |
| Intertissue Relationships In Metabolism Of Amino Acids | 7 | February 3, 2012 |
| TH4, B12, And SAM | 13 | February 2, 2012 |
| Pyrimidine Metabolism | 11 | February 2, 2012 |
| Module II Diseases And Drugs | 55 | February 2, 2012 |
| Purine Metabolism | 23 | February 2, 2012 |
| Synthesis And Degradation Of Amino Acids | 23 | February 2, 2012 |
| The Urea Cycle | 12 | February 2, 2012 |
| Intro To Nitrogen Metabolism | 16 | January 31, 2012 |
| Protein Diets | 12 | January 31, 2012 |
| Cholesterol Absorption, Synthesis, Metabolism, And Fate | 33 | January 28, 2012 |
| Synthesis Of Fatty Acids, Triacylglycerols, And Major Membrane Lipids | 32 | January 28, 2012 |
| Digestion And Transport Of Dietary Lipids | 14 | January 28, 2012 |
| Screening For Inborn Errors Of Metabolism | 14 | January 27, 2012 |
| Gluconeogenesis | 15 | January 27, 2012 |
| Glycosides, Lactose, Glycoproteins, And Glycolipids | 18 | January 27, 2012 |
| Pentose Phosphate Shunt | 8 | January 24, 2012 |
| Fructose And Galactose Metabolism | 9 | January 24, 2012 |
| Formation And Degradation Of Glycogen | 16 | January 23, 2012 |
| Oxidative Phosphorylation | 32 | January 22, 2012 |
| Oxidation Of Fatty Acids And Ketone Bodies | 18 | January 20, 2012 |
| Cellular Bioenergetics | 14 | January 20, 2012 |
| Tricarboxylic Acid Cycle | 18 | January 20, 2012 |
| Generation Of ATP From Glucose | 30 | January 19, 2012 |
| Intro To Carbohydrates | 15 | January 18, 2012 |
| Regulation Of Fuel Metabolism | 11 | January 18, 2012 |
| Overview Of Metabolism Nutritional States | 12 | January 18, 2012 |
| Clinical Values Reflect Metabolism | 54 | January 18, 2012 |
| Epigenetics | 16 | January 13, 2012 |
| Cell Proliferation And Cell Cycle | 34 | January 11, 2012 |
| Transcription Factors | 25 | January 11, 2012 |
| Genethics | 17 | January 10, 2012 |
| Eugenics | 14 | January 10, 2012 |
| Regulation Of Gene Expression | 26 | January 10, 2012 |
| Synthesis Of Proteins | 23 | January 9, 2012 |
| Synthesis Of RNA | 23 | January 9, 2012 |
| DNA Synthesis And Repair | 25 | January 9, 2012 |
| Intro To Inheritance | 27 | January 9, 2012 |
| Cell Signaling By Chemical Messengers | 28 | January 8, 2012 |
| Cell Transporters | 71 | January 8, 2012 |
| Metabolic Changes And Laboratory Testing | 10 | January 6, 2012 |
| Hemoglobinopathies | 28 | January 6, 2012 |
| Enzymes As Catalysts | 73 | January 5, 2012 |
| Hemoglobin Structure And Function | 20 | January 5, 2012 |
| PPCE I Drugs | 29 | January 5, 2012 |
| Endocrine Drugs | 14 | January 5, 2012 |
| Structure-Function Relationship Of Proteins | 18 | January 4, 2012 |
| Amino Acids In Proteins | 31 | January 4, 2012 |
| Molecular Pathology Approach | 16 | January 4, 2012 |
| Intro to Metabolism/Biochemistry of Nutrition | 77 | January 3, 2012 |